Active

Ambry Genetics Data Privacy Lawsuit (Tempus AI Lawsuit)

Protect Your Genetic Data

On May 6, 2026, the Court appointed David Berger to the Plaintiffs’ Executive Committee in the class action against Tempus AI, the acquirer of genetic testing lab Ambry Genetics, which alleges the company exploited patients’ most sensitive genetic data to train AI models without patients’ knowledge or consent.

If you used Ambry Genetics for genetic testing, your sensitive personal and medical information may have been put at risk. Our lawsuit examines whether patients’ genetic data was improperly shared or used to train AI models without customer knowledge or consent. We are actively reviewing cases for those who lived in Alaska, New Hampshire, New Mexico, Nevada, and Oregon.

Used Ambry Genetics for genetic testing? You may have a legal claim. Find out if you qualify.

Tell us about your experience with Ambry Genetics

loading...

Genetic Testing Patients May Be Impacted By Ambry Data Privacy Lawsuit

You may be affected by this alleged data privacy violation if: 

  1. You lived in Alaska, New Hampshire, New Mexico, Nevada, or Oregon, and 
  2. You underwent genetic testing performed by Ambry Genetics, and 
  3. You provided a blood or saliva sample for genetic analysis

Not Sure If You Used Ambry Genetics? You May Still Be Impacted

Many people receive genetic testing through their doctor or healthcare provider, particularly for: 

  • hereditary cancer risk testing 
  • cardiovascular genetic testing 
  • rare disease screening 
  • neurological genetic testing. 

In many cases, patients may not remember the name of the laboratory that performed their test. 

If your doctor ordered a genetic test and you submitted a DNA sample to evaluate inherited disease risk, your information may have been processed by Ambry Genetics and you may be affected.

Learn the Facts

Tempus AI’s Acquisition of Ambry Genetics

Ambry Genetics is a laboratory that performs genetic testing to identify inherited health risks, including hereditary cancer and rare diseases. Many patients provided blood or saliva samples to undergo these tests. 

Tempus AI is a healthcare technology company that builds artificial intelligence systems using vast medical datasets, to develop diagnostic tools and support pharmaceutical research. 

In 2025, Tempus AI purchased Ambry Genetics  — a company that had conducted millions of genetic tests on patients across the United States. 

Through this acquisition, Tempus gained access to a massive database of genetic testing information derived from patients’ DNA. 

Ambry Genetic Data Privacy Violations

Our lawsuit examines whether genetic information used for medical testing may have been: 

  • Improperly used to train artificial intelligence systems 
  • Shared with third parties without patient consent 
  • Used in a manner that violated state genetic data protection laws 

What To Do If You Had Genetic Testing or Cancer Risk Screening with Ambry Genetics 

If you underwent genetic testing through Ambry Genetics while living in Alaska, New Hampshire, New Mexico, Nevada, or Oregon, you can learn more about your legal rights.

Our attorneys are looking into whether patients’ genetic data may have been shared or used without consent at the time testing occurred.

Hiring Our Tempus AI Team: No Win, No Cost 

You do not pay us any money out of pocket. We will never ask you to send us money.

This means that pursuing a lawsuit against Tempus AI will cost you nothing. If we win, our fees come out of any verdict or settlement you receive at the end of the case.

Ambry Genetics Patients: Why Hire Our Data Privacy Attorneys?

Gibbs Mura’s attorneys have prosecuted some of the largest and most influential data breach cases in the country. Our work has resulted in billions of dollars in recoveries for consumers and has helped shape the laws protecting privacy rights in the digital age.

Flock Safety License Plate Reader Cameras — Class Action Lawsuit

Gibbs Mura filed a class action against Flock Safety on February 6, 2026 for allegedly using its automated license plate reader (ALPR) cameras to track millions of Californians’ daily movements and to illegally share this information with out-of-state law enforcement cities, violating California privacy laws.

Equifax Data Breach Lawsuit — $1.5 Billion Settlement

In 2017, Equifax, one of the three major consumer credit reporting agencies, exposed the Social Security numbers and personal information of more than 145 million Americans. Gibbs Mura was appointed by the court to help lead the litigation, which resulted in a historic $1.5 billion settlement — the largest data breach settlement in history. 

Anthem Data Breach Lawsuit — $115 Million Settlement

Gibbs Mura’s attorneys served in a court-appointed leadership role in the Anthem health insurance data breach class action on behalf of millions of patients whose medical information was exposed. The case resulted in a $115 million settlement, which was the largest data breach settlement in history at that time.

Meta Pixel Healthcare Data Breach — Class Action Lawsuit

Gibbs Mura partner Andre Mura was appointed by the court to serve on the Plaintiffs’ Executive Committee in the Meta Pixel Healthcare Litigation. The consolidated class action alleges that Meta secretly collected and shared sensitive health data of millions of patients without their consent through its Pixel tracking tool, which had been embedded on hospital websites and patient portals, in violation of HIPAA and consumer privacy laws.

Sequoia Benefits — HR & Payroll Data Breach Lawsuit

Gibbs Mura partner David Berger served as co-lead counsel in this data breach, of employee health benefits information and obtained an $8.75 million settlement on behalf individuals whose information was taken in the Sequoia Benefits data breach. The judge specifically noted Mr. Berger’s “especially strong expertise in handling data breach class action litigation.”

MGM Data Breach Lawsuit — $45 Million Settlement

Gibbs Mura partner David Berger served as Co-Lead Counsel and obtained a $45 million settlement on behalf of tens of millions of MGM customers whose information was compromised in a series of sophisticated data breaches.

Adobe — 38 Million User Data Breach Lawsuit

In November 2013, Gibbs Mura filed a class action lawsuit against Adobe after a breach affecting approximately 38 million users. The lawsuit alleged that Adobe failed to use industry-standard security practices, contrary to the company’s own stated privacy commitments.

Certegy Financial — Insider Data Theft Lawsuit

Gibbs Mura represented thousands of consumers after a Certegy Check Services employee sold customers’ financial and personal data to third parties. The case alleged that Certegy violated customers’ privacy rights and financial privacy laws by failing to implement adequate internal security controls.

Gibbs Mura is a nationwide leader in class action lawsuits seeking to hold companies accountable for large-scale data breaches and privacy lawsuits.  It has prosecuted some of the largest privacy cases throughout the country, and the firm’s attorneys have received numerous awards for their privacy and data breach work including “Cybersecurity & Privacy MVP,” “Top Cybersecurity and Privacy Attorneys Under 40,” and “Titans of the Plaintiffs Bar.” 

titan of plaintiffs bar award
best law firm ranking
chambers USA leading firms award
daily journal top plaintiff lawyers award

Our Privacy Team

David Berger
David Berger

David represents consumers in data breach, privacy, and financial services litigation. He has prosecuted some of the largest privacy cases nationwide.

Kate Walford
Kate Walford

Kate advocates on behalf of consumers in class action and complex litigation, with a particular focus on data privacy and data breach cases.

Eileen Epstein Carney
Eileen Epstein Carney

Eileen represents investors and consumers harmed by financial fraud and other corporate misconduct. She also executes on the firm's strategic vision.

Jennifer Sun
Jennifer Sun

Jennifer litigates against the world’s largest tech companies, holding them to account when they fail to protect consumers’ privacy and personal data.

Mark Patronella
Mark Patronella

Mark is passionate about holding corporations accountable for predatory and unfair conduct. He represents consumers with an emphasis on privacy law.

Start Your Claim in 3 Easy Steps

It’s free to sign up. You owe nothing unless we get you compensation.

Pencil icon

Fill Out The Contact Form

Enter your full legal name. Once you submit the form you will be taken to a short questionnaire.

Scales icon

Speak with Our Legal Team

Using the contact information you provide, our team will reach out to learn more about you and your story.

Send icon

Sign a Representation Agreement

If our attorneys determine we can represent you, you will need to sign a representation agreement.

Concerned About Your Genetic Data Being Shared? 

Additional FAQs 

Did Ambry Genetics share my genetic testing data with Tempus AI?

Many patients provided blood or saliva samples for genetic testing performed by Ambry Genetics, often through their doctor. 

In 2025, Tempus AI acquired Ambry Genetics. Public reporting and legal filings have raised questions about whether genetic testing data collected by Ambry may have been transferred or incorporated into Tempus AI’s large medical datasets following the acquisition. 

Our lawsuit examines whether genetic information provided for medical testing may have been shared, transferred, or used in ways patients did not expect or authorize. 

If you underwent genetic testing through Ambry Genetics while living in Alaska, New Hampshire, New Mexico, Nevada, or Oregon, you may wish to learn more about your rights. 

What is Ambry Genetics? 

Ambry Genetics is a laboratory that performs clinical genetic testing for healthcare providers. Doctors often send patient samples to labs like Ambry to analyze genetic markers associated with inherited diseases. 

Patients may not always remember the name of the laboratory that performed their test. 

Why is Tempus AI involved? 

Tempus AI is a healthcare technology company that uses large medical datasets and artificial intelligence to analyze disease patterns and support drug development. 

Tempus acquired Ambry Genetics in 2025, which reportedly gave the company access to Ambry’s genetic testing platform and its underlying data resources.

Oakland

1111 Broadway, Suite 2100

Oakland, CA 94607

© Gibbs Mura, A Law Group 2026